LTAS
Linden Thomas Advisory Services’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.77M | Buy |
127,426
+92,193
| +262% | +$2M | 0.3% | 90 |
|
|
2025
Q1 | $854K | Buy |
35,233
+2,594
| +8% | +$62.9K | 0.11% | 302 |
|
|
2024
Q4 | $681K | Buy |
32,639
+5,732
| +21% | +$120K | 0.09% | 347 |
|
|
2024
Q3 | $535K | Buy |
26,907
+5,581
| +26% | +$111K | 0.07% | 370 |
|
|
2024
Q2 | $330K | Buy |
21,326
+4,583
| +27% | +$71K | 0.05% | 395 |
|
|
2024
Q1 | $267K | Buy |
16,743
+5,666
| +51% | +$90.3K | 0.04% | 396 |
|
|
2023
Q4 | $186K | Buy |
+11,077
| New | +$186K | 0.03% | 412 |
|